Hippo/YAP signaling's multifaceted crosstalk in cancer

Jie Zhang1, Haipeng Wu1,2, Xinxin Ren3

  • 1Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, China.

Insights

The Hippo/yes-associated protein (YAP) pathway regulates organ size and is crucial in cancer. Its complex interactions with other signaling pathways influence tumor growth and metastasis, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • The Hippo/yes-associated protein (YAP) signaling pathway is a conserved regulator of organ size, influencing cell proliferation, differentiation, apoptosis, and regeneration.
  • Dysregulation of the Hippo/YAP pathway is a key driver in tumorigenesis, impacting various stages of cancer development.

Purpose of the Study:

  • To review the molecular mechanisms of Hippo/YAP signaling crosstalk with other pivotal pathways in cancer biology.
  • To explore the implications of these intricate regulatory networks on tumor initiation, progression, and metastasis.

Main Methods:

  • Literature review focusing on molecular mechanisms of signaling pathway interplay.
  • Analysis of Hippo/YAP interactions with NF-κB, Wnt/β-catenin, TGF-β, Hedgehog, and Notch pathways.
  • Examination of the role of these interactions in cancer development and progression.

Main Results:

  • Hippo/YAP signaling engages in extensive crosstalk with multiple pathways, forming complex regulatory networks.
  • This crosstalk contributes to the context-dependent influence of Hippo/YAP on tumor initiation, progression, and metastasis.
  • Specific pathway interactions, including with NF-κB, Wnt/β-catenin, TGF-β, Hedgehog, and Notch, are detailed.

Conclusions:

  • The intricate interplay between Hippo/YAP and other signaling pathways is critical in cancer biology.
  • Understanding these molecular mechanisms provides insights into tumor development and offers potential therapeutic strategies.
  • Targeting these crosstalk mechanisms may represent promising avenues for novel cancer therapies.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K